CompletedNCT03378258
Petechiae In Children (PIC) Study: Defining A Clinical Decision Rule for The Management Of Fever and Non-Blanching Rashes In Children Including The Role Of Point Of Care Testing For Procalcitonin & Neisseria Meningitidis DNA.
Studying Meningococcal meningitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Belfast Health and Social Care Trust
- Principal Investigator
- MIchael D ShieldsQueen's University, Belfast
- Enrollment
- 1329 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2017 – 2019
Study locations (1)
- Royal Belfast Hospital for Sick Children, Belfast, Northern Ireland, United Kingdom
Collaborators
Pediatric Emergency Research in the UK and Ireland (PERUKI) · Royal College of Emergency Medicine · Queen's University, Belfast · Public Health Agency (Northern Ireland)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03378258 on ClinicalTrials.govOther trials for Meningococcal meningitis
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGPHASE3NCT06995430A Phase 3 Study to Assess the Immune Response And Safety Of Rmenb+Omv Nz In Primed Healthy Participants (10 To 20 Years Old)GlaxoSmithKline
- RECRUITINGPHASE4NCT06832514Investigating Gender and Sex Differences in Immune Responses Through Vaccination of Transgender and Cisgender PersonsUniversity Ghent
- ACTIVE NOT RECRUITINGPHASE3NCT06700148A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in 7 to 17 Year OldsCanSino Biologics Inc.
- ACTIVE NOT RECRUITINGPHASE3NCT06131554A Clinical Trial to Evaluate the Immunogenicity and Safety of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) in Adults Aged 18 to 55 YearsCanSino Biologics Inc.
- ACTIVE NOT RECRUITINGPHASE3NCT06226714A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in 18-59 Year OldsCanSino Biologics Inc.
- RECRUITINGNCT04664569National Bacterial Meningitis StudyAssociation Clinique Thérapeutique Infantile du val de Marne